Table 2.
Female VI (n=403)* | Female GP (n=941)* | P values† | Male VI (n=333)* | Male GP (n=828)† | P values† | |||||
Cases/tot | % (95% CI) | Cases/tot | % (95% CI) | Cases/tot | % (95% CI) | Cases/tot | % (95% CI) | |||
Age groups (years) | ||||||||||
18–35 | 15/88 | 17.1 (10.5 to 26.5) | 22/189 | 11.6 (7.8 to 17.1) | 0.26 | 1/69 | 1.5 (0.2 to 9.7) | 1/105 | 1.0 (0.1 to 6.5) | 1.00 |
36–50 | 26/101 | 25.7 (18.1 to 35.2) | 31/273 | 11.4 (8.1 to 15.7) | 0.001 | 4/85 | 4.7 (1.8 to 12.0) | 3/184 | 1.6 (0.5 to 5.0) | 0.21 |
51–65 | 17/106 | 16.0 (10.2 to 24.4) | 28/267 | 10.5 (7.3 to 14.8) | 0.16 | 2/94 | 2.1 (0.5 to 8.2) | 6/286 | 2.1 (0.9 to 4.6) | 1.00 |
≥66 | 12/108 | 11.1 (6.4 to 18.6) | 13/212 | 6.1 (3.6 to 10.3) | 0.13 | 1/85 | 1.2 (0.2 to 8.0) | 4/253 | 1.6 (0.6 to 4.1) | 1.00 |
Total | 70/403 | 17.4 (14.0 to 21.4) | 94/941 | 10.0 (8.3 to 12.1) | <0.001 | 8/333 | 2.4 (1.2 to 4.7) | 14/828 | 1.7 (1.0 to 2.8) | 0.48 |
*No missing data due to non-response for the VI population, while there were 23 participants from the general population who did not respond to questions related to age and/or gender.
†P value calculated using Fisher’s exact test.
tot, total number of participants in that particular subgroup.